Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Susan M Learned"'
Autor:
Ruihua Dong, Hongyun Wang, Dandan Li, Liwei Lang, Frank Gray, Yongzhen Liu, Celine M. Laffont, Malcolm Young, Ji Jiang, Zeyuan Liu, Susan M. Learned
Publikováno v:
Drugs in R&D, Vol 19, Iss 3, Pp 255-265 (2019)
Abstract Background Two phase I studies assessed the pharmacokinetics of buprenorphine, its metabolite norbuprenorphine, and naloxone following administration of buprenorphine/naloxone sublingual tablets in Chinese participants. Methods In the first
Externí odkaz:
https://doaj.org/article/79bde2a917974800ab91d5b4112163f5
Autor:
Caitlyn T. Solem, Walter Ling, Naoko A Ronquest, Vishaal Mehra, Yu-Chen Yeh, Christian Heidbreder, Vijay R Nadipelli, Susan M Learned
Publikováno v:
Journal of Substance Abuse Treatment. 110:1-8
The physical, social, psychological, and economic burden of opioid use disorder (OUD) is substantial. As of the year 2019, the predominant focus of OUD research was outcomes such as retention and abstinence. We report herein the effects of extended-r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af56f408f2a756beccebddd60779115d
https://doi.org/10.1016/j.jsat.2019.11.004
https://doi.org/10.1016/j.jsat.2019.11.004
Autor:
Walter Ling, Vishaal Mehra, Caitlyn T. Solem, Christian Heidbreder, Vijay R Nadipelli, Susan M Learned, Yu-Chen Yeh, Naoko A Ronquest
Publikováno v:
Journal of Addiction Medicine
Supplemental Digital Content is available in the text
Objective: Opioid use disorder (OUD) is associated with physical, social, psychological, and economic burden. This analysis assessed the effects of RBP-6000, referred to as BUP-XR (extended-r
Objective: Opioid use disorder (OUD) is associated with physical, social, psychological, and economic burden. This analysis assessed the effects of RBP-6000, referred to as BUP-XR (extended-r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d51f73937010daebc4c2fde9e75f0cf6
https://doi.org/10.1097/adm.0000000000000517
https://doi.org/10.1097/adm.0000000000000517
Autor:
Namita Joshi, Maurizio Fava, Caitlyn T. Solem, Della Varghese, Susan M Learned, James A Graham, Christian Heidbreder, Vijay R Nadipelli, Rahul Dhanda
Publikováno v:
Patient Preference and Adherence. 13:1037-1050
Purpose RBP-7000 (PERSERIS™) is a once-monthly subcutaneous extended-release risperidone formulation approved by the United States Food and Drug Administration for the treatment of schizophrenia in adults. The objective of this study was to describ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fb3c4cb014737fb68d23477d1ffecda
https://doi.org/10.2147/ppa.s202173
https://doi.org/10.2147/ppa.s202173
Autor:
Dandan Li, Liwei Lang, Frank Gray, Hongyun Wang, Malcolm A. Young, Ji Jiang, Zeyuan Liu, Céline M. Laffont, Ruihua Dong, Susan M Learned, Yongzhen Liu
Publikováno v:
Drugs in R&D
Drugs in R&D, Vol 19, Iss 3, Pp 255-265 (2019)
Drugs in R&D, Vol 19, Iss 3, Pp 255-265 (2019)
Background Two phase I studies assessed the pharmacokinetics of buprenorphine, its metabolite norbuprenorphine, and naloxone following administration of buprenorphine/naloxone sublingual tablets in Chinese participants. Methods In the first phase I,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c8ab17c278e417c8cd6e813ec459e8c
https://doi.org/10.1007/s40268-019-0277-9
https://doi.org/10.1007/s40268-019-0277-9
Autor:
Brian Perrochet, Naoko A Ronquest, Walter Ling, Chinmay Deshpande, David Farabee, Christian Heidbreder, Vijay R Nadipelli, Susan M Learned, Caitlyn T. Solem
Publikováno v:
Substance Abuse and Rehabilitation. 10:13-21
Purpose: The Treatment Effectiveness Assessment (TEA) is a patient-centered instrument for evaluating treatment progress and recovery from substance use disorders, including opioid use disorder (OUD). We assessed the TEA's reliability and validity an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f72289073d3df8f30685a2da12462a51
https://doi.org/10.2147/sar.s198361
https://doi.org/10.2147/sar.s198361
Autor:
Vishaal Mehra, James L. Andersen, Michael J. Biunno, Jelena Kunovac, Walter Ling, Barbara R. Haight, Saleem Ishaque, David R. Hassman, Gregory Seal, Scott Daniel Segal, Amanda S. Garofalo, Jesse M. Carr, Valentin Isacesu, Rakesh Ranjan, Ricky Stuart Mofsen, Otto R. Dueno, Kent Steven Hoffman, Paul J. Fudala, Brent Boyett, Shishuka Malhotra, Lawrence S. Levinson, Céline M. Laffont, Peter Paul Ventre, Eduardo Cifuentes, Sandra Daniela Duarte-Sckell, Scott Robert Bartley, Genie L. Bailey, Richard D. Knapp, Gita G. Pujari, Kyle M. Kampman, Rajinder Shiwach, Christian Heidbreder, Vijay R Nadipelli, Daniel Rutrick, Y Zhao, Rishi Kakar, Katharina Wiest, Marvin Lane Peyton, David P. Walling, Susan M Learned, Joseph A. Kwentus, Amit K. Vijapura, Haydn Mikel Thomas, Boyde J. Harrison, Mark K. Greenwald, George Konis
Publikováno v:
The Lancet. 393:778-790
RBP-6000, referred to as BUP-XR (extended-release buprenorphine), is a subcutaneously injected, monthly buprenorphine treatment for opioid use disorder. BUP-XR provides sustained buprenorphine plasma concentrations to block drug-liking of abused opio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d956456416ef2fa898c563ec73fed86b
https://doi.org/10.1016/s0140-6736(18)32259-1
https://doi.org/10.1016/s0140-6736(18)32259-1
Autor:
Arnie Aldridge, Naoko A Ronquest, Christian Heidbreder, Vijay R Nadipelli, Victoria A Albright, Susan M Learned, Vishaal Mehra, Walter Ling
Publikováno v:
Contemporary Clinical Trials. 76:93-103
Few opioid use disorder (OUD) treatment studies measure meaningful life changes during long-term recovery, focusing instead on retention and abstinence. Here, we report on the design and participant characteristics of the RECOVER study, a study explo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bd6d1d55d4bfa70d5add2da095da633
https://doi.org/10.1016/j.cct.2018.11.015
https://doi.org/10.1016/j.cct.2018.11.015
Autor:
Barbara R. Haight, Norma Lynn Fox, Sunita Shinde, Anne Andorn, David R. Hassman, Paul J. Fudala, Susan M Learned, Christian Heidbreder, Vijay R Nadipelli, Daniel Rutrick, Y Zhao
Publikováno v:
Journal of Clinical Psychopharmacology
Supplemental digital content is available in the text.
Background BUP-XR (RBP-6000 or SUBLOCADE) is the first Food and Drug Administration–approved subcutaneously administered monthly extended-release buprenorphine medication for the treatment
Background BUP-XR (RBP-6000 or SUBLOCADE) is the first Food and Drug Administration–approved subcutaneously administered monthly extended-release buprenorphine medication for the treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e7f24f63585d4b3e1294bd57656ffd4
https://pubmed.ncbi.nlm.nih.gov/32282418
https://pubmed.ncbi.nlm.nih.gov/32282418
Autor:
Arnie Aldridge, Walter Ling, Christian Heidbreder, Vijay R Nadipelli, Susan M Learned, Courtney Johnson, Victoria Albright, Caitlyn T Solem, Naoko A Ronquest, Howard Chilcoat, Vishaal Mehra
Publikováno v:
Journal of Addiction Medicine
Objectives While evidence has mounted regarding the short-term effectiveness of pharmacotherapy for opioid use disorder (OUD), little is known about longer-term psychosocial, economic, and health outcomes. We report herein 12-month outcomes for an ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::679bdb7955be876c3c42b133240ed8e2
https://pubmed.ncbi.nlm.nih.gov/32187112
https://pubmed.ncbi.nlm.nih.gov/32187112